Democrats' Stumble on Drug Prices Shows Power of Industry

France Nouvelles Nouvelles

Democrats' Stumble on Drug Prices Shows Power of Industry
France Dernières Nouvelles,France Actualités
  • 📰 YahooNews
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 59%

The United States pays higher prices for prescription drugs than any of its peers — about 250% of the price paid on average by other Organization for Economic Cooperation and Development countries, according to a recent report from the Rand Corp.

A Democratic plan to reduce drug prices stalled on Wednesday in the House Energy and Commerce Committee. House Democrats writing the health provisions of their big social spending bill aimed high: new coverage for poor Americans without insurance; extra subsidies for people who buy their own coverage; and new dental, hearing and vision benefits for older Americans through Medicare.

The dynamic is familiar to lawmakers who have worked on health issues: Health industries are large and powerful lobbies, and they do not enjoy having their revenues cut. As with measures that might reduce payments to hospitals, doctors and insurance companies, the House’s attempt to take a bite out of drug companies has generated a backlash.

And those high costs ripple through the federal budget and the economy, increasing insurance premiums and putting lifesaving medications out of reach for some patients.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

YahooNews /  🏆 380. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Democrats' sweeping healthcare expansion at risk amid new clash over drug pricingDemocrats' sweeping healthcare expansion at risk amid new clash over drug pricingDemocrats are sharply divided over whether to require drugmakers to negotiate their prices with the federal government.
Lire la suite »

Column: Drugmakers see disaster in Medicare negotiating prices. Don't listen to themColumn: Drugmakers see disaster in Medicare negotiating prices. Don't listen to them'The pharmaceutical industry, bizarrely, told the American people this week that allowing Medicare to negotiate drug prices is tantamount to socialism, rather than an example of a healthy, competitive marketplace.' Column by Davidlaz:
Lire la suite »

Centrist Democrats scramble House drug pricing effortCentrist Democrats scramble House drug pricing effortThree centrist House Dems threw their party's health care agenda into disarray today by blocking a plan that would have authorized direct government negotiation of drug prices and help pay for a $3.5 trillion social spending bill
Lire la suite »

On’s IPO Is A ‘Starting Line’ For The Fastest-Growing Athletic Shoe Brand In U.S.On’s IPO Is A ‘Starting Line’ For The Fastest-Growing Athletic Shoe Brand In U.S.Launched in 2010 by Olivier Bernhard, Caspar Coppetti and David Allemann with the brand's unique CloudTec technology for running, the distinct outsole technology quickly caught on in the running community with the Cloud silhouette and the brand immediately expanded out of Switzerland.
Lire la suite »

Column: Surging European gas prices to drive down pre-winter demand: KempColumn: Surging European gas prices to drive down pre-winter demand: KempEuropean gas prices are surging on tight inventories heading into winter, incentivising power producers to switch back to coal and industrial users to consider temporary plant closures.
Lire la suite »

UK inflation rate posts biggest increase since records beganUK inflation rate posts biggest increase since records beganThe U.K.'s consumer prices index surged by 3.2% in the 12 months to August, official data showed on Wednesday, the largest ever month-on-month increase since records began.
Lire la suite »



Render Time: 2025-04-05 16:28:48